v3.26.1
Segments - Schedule of Significant Segment Expenses Regularly Provided to the CODM (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Research and development expenses:    
Other indirect research and development expenses $ 514 $ 392
Total research and development expenses 21,431 10,534
General and administrative expenses:    
Other general and administrative expenses [1] 1,988 2,627
Total general and administrative expenses 6,112 5,651
Other segment items [2] (2,135) (3,060)
Net loss 25,408 13,125
Preclinical and Early Discovery Assets    
Research and development expenses:    
Total research and development expenses 944 821
Personnel-related    
Research and development expenses:    
Total research and development expenses 4,600 3,156
General and administrative expenses:    
Total general and administrative expenses 4,124 3,024
GlyphAllo Direct Research and Development Expenses    
Research and development expenses:    
Total research and development expenses 8,297 3,309
GlyphAgo Direct Research and Development Expenses    
Research and development expenses:    
Total research and development expenses 6,494 1,960
Glyph2BLSD Direct Research and Development Expenses    
Research and development expenses:    
Total research and development expenses $ 582 $ 896
[1] Other general and administrative expenses include professional fees, facilities, depreciation, IT, and other expenses.
[2] Other segment items include interest income, net, research and development tax credit, income tax provision, and other expense, net.